Role of conserved serine residues in the interaction of agonists with D3 dopamine receptors

Journal of Neurochemistry

Volumn 72, Issue 6, 1999, Pages 2621-2624

  Sartania, Nana ^a   Strange, Philip G ^b  

^a UNIVERSITY OF KENT   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Agonists; D3 dopamine receptor; Ligand binding; Serine residues

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; BUTACLAMOL; COMPLEMENTARY DNA; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; QUINPIROLE; SERINE; SPIPERONE; TRITIUM;

ARTICLE; BINDING SITE; EMBRYO; HUMAN; HUMAN CELL; KIDNEY CELL; LIGAND BINDING; MUTAGENESIS; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR BINDING;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING SITES; BINDING, COMPETITIVE; CELL LINE; CONSERVED SEQUENCE; DOPAMINE; DOPAMINE AGONISTS; HUMANS; KIDNEY; KINETICS; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SERINE; SPIPERONE; TETRAHYDRONAPHTHALENES; TRITIUM;

EID: 0033045716     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0722621.x     Document Type: Article

References (9)

1. 2 dopamine receptor mRNA. Brain Res. 564, 203-219.
2. 3 dopamine receptors to G-proteins. FEBS Lett. 315, 223-226.
3. 2 dopamine receptors. Mol. Pharmacol. 45, 51-60.
4. 2 receptors. J. Neurochem. 59, 627-635.
5. 2 dopamine receptor. Eur. J. Pharmacol. 227, 205-214.
6. Neve K. A. and Neve R. L. (1997) The Dopamine Receptors. Humana Press, Totowa, New Jersey.
7. Sokoloff P. and Schwartz J. C. (1995) Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16, 270-275.
8. 3) as a target for neuroleptics. Nature 347, 146-151.
9. 2 dopamine receptor using site-directed mutagenesis. J. Neurochem. 66, 394-402.